# Exisulind Prior to Radical Prostatectomy

> **NCT00166478** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 130 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** Exisulind Therapy

## Key facts

- **NCT ID:** NCT00166478
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2010-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00166478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00166478, "Exisulind Prior to Radical Prostatectomy". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00166478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*